account_id none on file
legal_name Standard Biotools Inc.
ticker LAB
cik 1162194
domain standardbio.com
linkedin_company_url https://www.linkedin.com/company/standard-biotools
entry_point_account_id none on file
name Standard BioTools Inc.
exchange Nasdaq
sector Industrials
hq Boston, MA, United States
sector index/company/sector/industrials/
calls 1 filings 16 executives 3 family 0
why_nownone on file
calls
And we've seen at the recent AACR conference a number of customers from academia could not travel because there were basically curbing all non-essential expenditures.
May 6, 2025 / receipt, needs a key / Matt Stanton, other | earnings call 2025-05-06 | transcript c5aa5fce-155c-48f1-a987-fcc7b1c9beb0 | chars 29079-29245 | segment 29
filings
A potential third-party acquirer maintaining interest in the face of these provisions might propose to pay a lower price to our stockholders than it might otherwise have proposed to pay because of the added expense of the termination fee and expense reimbursement described above.
filing / Aug 5, 2026 / receipt
Jeffrey Engelman, currently the chief scientific officer and co-founder of Treeline, will serve as Chief Scientific Officer of the combined company, and Spencer Smith, currently the chief financial officer of Treeline, will serve as Chief Financial Officer of the combined company.
filing / Aug 5, 2026 / receipt
Upon termination under specified circumstances, the Company may be required to pay Treeline a termination fee of $16.1 million or to reimburse Treeline's transaction expenses up to $5.0 million (with any such expense reimbursement credited against any such termination fee).
filing / Aug 5, 2026 / receipt
growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition activity and restructuring plans (including expense reduction activities, modifications to the scope of our proteomic and genomics businesses, and discontinuing certain product lines), our expectations regarding the benefits and integration of acquired bus
filing / Aug 5, 2026 / receipt
Additionally, marketing and advertising expense declined by $2.4 million, and consulting fees declined by $1.8 million due to an increased focus by management on expense reduction during 2026.
filing / Aug 5, 2026 / receipt
controls and tariffs, potential growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition activity and restructuring plans (including expense reduction activities, modifications to the scope of our proteomic and genomics businesses, and discontinuing certain product lines), our expectations regarding the benefits
filing / Aug 5, 2026 / receipt
growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition activity and restructuring plans (including expense reduction activities, modifications to the scope of our proteomic and genomics businesses, and discontinuing certain product lines), our expectations regarding the benefits and integration of acquired bus
filing / May 6, 2026 / receipt
controls and tariffs, potential growth opportunities, market growth expectations, the effects of competition, cost structure optimization, acceleration of growth, potential merger and acquisition activity and restructuring plans (including expense reduction activities, modifications to the scope of our proteomic and genomics businesses, and discontinuing certain product lines), our expectations regarding the benefits
filing / May 6, 2026 / receipt
These costs, including a reduction in force, are incurred to improve operational efficiency, achieve cost savings and align our workforce to the future needs of the business.
filing / May 6, 2026 / receipt
The increase was further driven by $0.9 million of additional severance and related benefits associated with workforce reductions initiated in the prior year, partially offset by lower severance costs from current-period workforce reductions.
filing / May 6, 2026 / receipt
Field Service Engineer | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Remote---Italy/Field-Service-Engineer_2026-0031", "remote": true, "category": "other", "function": "engineering
company_statement / Sep 1, 2026 / receipt
Service Sales Manager | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Remote---Georgia/Service-Sales-Manager_2026-0029", "remote": true, "category": "sales_expansion", "function": "s
company_statement / Aug 26, 2026 / receipt
executives
| Alex Kim | Chief Financial Officer | receipt | |
| Jeffrey G. Black | Chief Financial Officer | - | receipt |
| Michael Egholm | CEO | - | receipt |
familynone on file
upcoming
| 2026-11-03 | earnings call | scheduled | ir |
changes
| 2024-11-07 | Interim Chief Financial Officer, appointed | sec_8k |
| 2024-07-31 | Interim Chief Financial Officer, appointed | sec_8k |
| 2024-07-31 | Senior Vice President and Chief Financial Officer, departed | sec_8k |
| 2023-05-15 | Chief Financial Officer, appointed | sec_8k |
mcp_package_hint
slug standard-biotools-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$